ZA902353B - Suppression of parathyroid hormone synthesis and secretion - Google Patents
Suppression of parathyroid hormone synthesis and secretionInfo
- Publication number
- ZA902353B ZA902353B ZA902353A ZA902353A ZA902353B ZA 902353 B ZA902353 B ZA 902353B ZA 902353 A ZA902353 A ZA 902353A ZA 902353 A ZA902353 A ZA 902353A ZA 902353 B ZA902353 B ZA 902353B
- Authority
- ZA
- South Africa
- Prior art keywords
- secretion
- suppression
- parathyroid hormone
- hormone synthesis
- hyperparathyroidism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/329,606 US4948789A (en) | 1989-03-28 | 1989-03-28 | Suppression of parathyroid hormone synthesis and secretion |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA902353B true ZA902353B (en) | 1990-12-28 |
Family
ID=23286199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA902353A ZA902353B (en) | 1989-03-28 | 1990-03-27 | Suppression of parathyroid hormone synthesis and secretion |
Country Status (15)
Country | Link |
---|---|
US (1) | US4948789A (ko) |
EP (1) | EP0390114B1 (ko) |
JP (1) | JPH0686382B2 (ko) |
KR (1) | KR0153532B1 (ko) |
AT (1) | ATE111737T1 (ko) |
AU (1) | AU618506B2 (ko) |
CA (1) | CA2013166C (ko) |
DE (1) | DE69012620T2 (ko) |
DK (1) | DK0390114T3 (ko) |
ES (1) | ES2063852T3 (ko) |
HK (1) | HK66895A (ko) |
HU (1) | HU211597A9 (ko) |
IE (1) | IE64949B1 (ko) |
IL (1) | IL93896A (ko) |
ZA (1) | ZA902353B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5063221A (en) * | 1989-04-05 | 1991-11-05 | Chugai Seiyaku Kabushiki Kaisha | Treatment for hyperparathyroidism with use of vitamin d derivatives |
GB9017890D0 (en) | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
GB9220272D0 (en) * | 1992-09-25 | 1992-11-11 | Leo Pharm Prod Ltd | Chemical compounds |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化1α−ヒドロキシビタミンD |
WO2002017911A1 (fr) * | 2000-08-30 | 2002-03-07 | Teijin Limited | Inhibiteurs de la production de parathormone contenant des derives de vitamine d3 |
US7129230B2 (en) | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
KR20040012983A (ko) * | 2001-07-03 | 2004-02-11 | 추가이 세이야쿠 가부시키가이샤 | 2차성 부갑상선 기능 항진증의 치료용 의약 조성물 및2차성 부갑상선 기능 항진증 치료에 수반되는 심혈관계합병증의 치료약 |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US7094775B2 (en) | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0184112B1 (en) * | 1984-11-27 | 1990-05-09 | Chugai Seiyaku Kabushiki Kaisha | Novel vitamin d derivatives and process for producing the same |
US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
-
1989
- 1989-03-28 US US07/329,606 patent/US4948789A/en not_active Expired - Lifetime
-
1990
- 1990-03-22 AU AU52106/90A patent/AU618506B2/en not_active Expired
- 1990-03-23 IE IE108390A patent/IE64949B1/en not_active IP Right Cessation
- 1990-03-26 IL IL9389690A patent/IL93896A/en not_active IP Right Cessation
- 1990-03-27 KR KR1019900004135A patent/KR0153532B1/ko not_active IP Right Cessation
- 1990-03-27 ZA ZA902353A patent/ZA902353B/xx unknown
- 1990-03-27 CA CA002013166A patent/CA2013166C/en not_active Expired - Lifetime
- 1990-03-28 ES ES90105922T patent/ES2063852T3/es not_active Expired - Lifetime
- 1990-03-28 EP EP90105922A patent/EP0390114B1/en not_active Expired - Lifetime
- 1990-03-28 DE DE69012620T patent/DE69012620T2/de not_active Expired - Lifetime
- 1990-03-28 JP JP2080544A patent/JPH0686382B2/ja not_active Expired - Lifetime
- 1990-03-28 DK DK90105922.0T patent/DK0390114T3/da active
- 1990-03-28 AT AT90105922T patent/ATE111737T1/de not_active IP Right Cessation
-
1995
- 1995-05-04 HK HK66895A patent/HK66895A/xx not_active IP Right Cessation
- 1995-06-30 HU HU95P/P00670P patent/HU211597A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HK66895A (en) | 1995-05-12 |
JPH037231A (ja) | 1991-01-14 |
EP0390114A2 (en) | 1990-10-03 |
CA2013166C (en) | 2001-01-02 |
KR900013965A (ko) | 1990-10-22 |
JPH0686382B2 (ja) | 1994-11-02 |
DE69012620T2 (de) | 1995-03-23 |
EP0390114B1 (en) | 1994-09-21 |
HU211597A9 (en) | 1995-12-28 |
AU618506B2 (en) | 1991-12-19 |
EP0390114A3 (en) | 1991-10-30 |
AU5210690A (en) | 1990-10-04 |
DK0390114T3 (da) | 1994-10-17 |
ATE111737T1 (de) | 1994-10-15 |
IL93896A (en) | 1994-10-21 |
US4948789A (en) | 1990-08-14 |
KR0153532B1 (ko) | 1998-11-16 |
IE901083L (en) | 1990-09-28 |
IE64949B1 (en) | 1995-09-20 |
DE69012620D1 (de) | 1994-10-27 |
CA2013166A1 (en) | 1990-09-28 |
ES2063852T3 (es) | 1995-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA902353B (en) | Suppression of parathyroid hormone synthesis and secretion | |
IL101819A0 (en) | Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants | |
ES2001341A6 (es) | Un procedimiento de producir un derivado de acido guanidinometilbenzoico. | |
DE3664909D1 (en) | Vitamin d3 derivatives | |
GR3001506T3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
HUT55385A (en) | Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components | |
DE3363550D1 (en) | New nitro aliphatic compounds, process for preparation thereof and use thereof | |
AU580086B2 (en) | New steroids substituted at position 10 by a radical including a double or triple bond, their preparation process, their use as medicaments, pharmaceutical compositions containing them | |
HK1005015A1 (en) | Osteogenesis promotion with use of vitamin d derivatives | |
GB8908700D0 (en) | Compounds | |
SE8205868L (sv) | Vissa 4-fenyl-4-oxo-2-butensyraderivat till anvendning som lekemedel och kompositioner innehallande dem | |
IL134199A0 (en) | MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES | |
YU92390A (en) | New derivatives of 9-alpha-hydroxy-3-oxo-2,24(25)-stigmastadien-26-ic acid and a process for obtaining | |
ES8301919A1 (es) | Procedimiento para preparar derivados de indano | |
HUT58471A (en) | Herbicidal composition comprising (sulfamidosulfonyl)-urea derivatives as active ingredient and process for producing the active ingredients | |
ZA869742B (en) | Novel pregnane derivatives,processes for their preparation and pharmaceutical compositions containing same | |
HUT68015A (en) | New compound leustroducsin h, its preparation and pharmaceutical compositions containing them | |
EP0444424A3 (en) | Bile acid unsaturated derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
ES467635A1 (es) | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-disubstituidos |